Jordan Smith
Family · Flowood, MSNPI 1013514553
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 723 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,027, 2.3 times the $1,327 reported in 2021. Among family clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 723 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Amgen$2K
- UCB, Inc.$1K
- Johnson & Johnson$1K
- Novartis$727
- AstraZeneca$510
- plus $3K from 18 others
What the payments were for
- Food & beverage$12,28299%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 177 | $2,886 |
| Amgen(2 entities) | 147 | $2,339 |
| UCB, Inc. | 76 | $1,359 |
| Johnson & Johnson | 71 | $1,237 |
| Novartis | 57 | $727 |
| AstraZeneca(2 entities) | 30 | $510 |
| GSK | 23 | $462 |
| Boehringer Ingelheim | 20 | $401 |
| Mallinckrodt Hospital Products Inc. | 16 | $390 |
| Genentech USA, Inc. | 22 | $382 |
| E.r. Squibb & Sons, L.L.C. | 16 | $353 |
| Lilly USA, LLC | 16 | $274 |
| Pfizer | 13 | $260 |
| Sobi, Inc | 9 | $182 |
| Aurinia Pharma U.S., Inc. | 6 | $124 |
| Fresenius Kabi USA, LLC | 5 | $97 |
| Radius Health, Inc. | 4 | $92 |
| ANI Pharmaceuticals, Inc. | 4 | $89 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Invivyd Inc | 2 | $40 |
| Actelion Pharmaceuticals US, Inc. | 2 | $38 |
| Sanofi | 2 | $33 |
| Ferring Pharmaceuticals Inc. | 1 | $28 |
| Tersera Therapeutics LLC | 1 | $16 |
How this compares
$12,382 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 367 | $12,585 |
| Leflunomide | 93 | $5,578 |
| MethotrexateMethotrexate Sodium | 229 | $4,515 |
| Sulfasalazine | 143 | $3,165 |
| Sulfasalazine DrSulfasalazine | 82 | $2,507 |
| Duloxetine Hcl | 59 | $988 |
| Gabapentin | 74 | $608 |
| Folic Acid | 35 | $495 |
| Prednisone | 84 | $479 |
| Celecoxib | 14 | $430 |
| Tizanidine Hcl | 30 | $302 |
| Cyclobenzaprine Hcl | 21 | $247 |
| Allopurinol | 23 | $172 |
| Alendronate Sodium | 25 | $117 |
| Omeprazole | 15 | $48 |
Paid to pharmacies, not to this prescriber.
Other family in Flowood
- Maranda EversollFlowood$197K
- Ashley CocilovaFlowood$72K
- Tina GreggFlowood$20K
- Christina PerkinsFlowood$14K
- Shara BeckwithFlowood$12K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.